HIF-1α and HIF-2α can lead to the induction of programmed death-ligand 1 (PD-L1) and the infiltration of tumor-associated macrophages (TAMs), respectively, thereby limiting anti-cancer immunity [17,18]. Here, HIF1A is linked to neoplasm.